TW200523266A - Method of purifying macrolides - Google Patents

Method of purifying macrolides Download PDF

Info

Publication number
TW200523266A
TW200523266A TW093122295A TW93122295A TW200523266A TW 200523266 A TW200523266 A TW 200523266A TW 093122295 A TW093122295 A TW 093122295A TW 93122295 A TW93122295 A TW 93122295A TW 200523266 A TW200523266 A TW 200523266A
Authority
TW
Taiwan
Prior art keywords
volume
tetrahydrofuran
resin bed
macrolide
dissolving agent
Prior art date
Application number
TW093122295A
Other languages
English (en)
Chinese (zh)
Inventor
Vilmos Keri
Zoltan Czovek
Andrea Csorvasi
Ferenc Rantal
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of TW200523266A publication Critical patent/TW200523266A/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TW093122295A 2003-07-24 2004-07-26 Method of purifying macrolides TW200523266A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49007003P 2003-07-24 2003-07-24
US53936304P 2004-01-26 2004-01-26

Publications (1)

Publication Number Publication Date
TW200523266A true TW200523266A (en) 2005-07-16

Family

ID=34107827

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093122295A TW200523266A (en) 2003-07-24 2004-07-26 Method of purifying macrolides

Country Status (13)

Country Link
US (2) US7220357B2 (https=)
EP (1) EP1558622B1 (https=)
JP (1) JP2007521013A (https=)
KR (1) KR20060052874A (https=)
AT (1) ATE378345T1 (https=)
CA (1) CA2533548C (https=)
DE (1) DE602004010059T2 (https=)
DK (1) DK1558622T3 (https=)
ES (1) ES2297481T3 (https=)
PL (1) PL1558622T3 (https=)
PT (1) PT1558622E (https=)
TW (1) TW200523266A (https=)
WO (1) WO2005010015A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7645876B2 (en) * 2004-12-01 2010-01-12 TEVA Gyógyszergyár Zártkörúen Müködö Részvénytársaság Processes for producing crystalline macrolides
RU2317991C1 (ru) * 2003-12-05 2008-02-27 Байокон Лимитид Способ выделения и очистки макролидов
WO2006069333A1 (en) * 2004-12-22 2006-06-29 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Method of purifying macrolides
BRPI0619592A2 (pt) * 2005-12-07 2016-09-06 Wyeth Corp métodos para medir a qualidade da partícula de um composto de rapamicina, para determinar o tamanho de partícula médio de uma amostra e a cristalinidade de um composto de rapamicina, e para a purificação de rapamicina
KR100859670B1 (ko) * 2006-09-13 2008-09-23 동국제약 주식회사 타크로리무스를 고수율 및 고순도로 정제하는 방법
CA2668134A1 (en) * 2006-11-06 2008-05-15 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Ascomycin and pimecrolimus having reduced levels of des-methylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
KR100891313B1 (ko) * 2007-08-17 2009-03-31 (주) 제노텍 담체로 작용하는 흡착성 수지의 제공에 의한 트리사이클로화합물의 생산 및 추출 방법
PL2792254T3 (pl) * 2009-04-16 2017-06-30 Ocean Spray Cranberries, Inc. Ekstrakcja związków fenolowych i ich zastosowanie w kompozycjach z kwasem fumarowym
CN106478664B (zh) * 2016-08-29 2017-12-05 广东蓝宝制药有限公司 一种发酵液中提取纯化他克莫司的方法
PL3619215T3 (pl) 2017-05-01 2022-03-21 Meda Pharma Gmbh & Co. Kg Sposób przekształcania surowej askomycyny w oczyszczony pimecrolimus
CN108409751A (zh) * 2018-02-24 2018-08-17 海正药业(杭州)有限公司 一种子囊霉素的纯化方法
CN111693635A (zh) * 2020-07-23 2020-09-22 北京和合医学诊断技术股份有限公司 检测血液中雷帕霉素含量的方法
CN113325108B (zh) * 2021-06-04 2022-12-09 山东霆科药业有限公司 一种他克莫司软膏的样品前处理方法
CN115716839A (zh) * 2022-11-15 2023-02-28 无锡福祈制药有限公司 一种依维莫司杂质的合成方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2121517C3 (de) 1971-04-30 1974-06-27 Leningradskij Nautschno-Issledowatelskij Institut Antibiotikow, Ssr, Leningrad (Sowjetunion) Verfahren zur Gewinnung von Amphoterizin B
US3993749A (en) 1974-04-12 1976-11-23 Ayerst Mckenna And Harrison Ltd. Rapamycin and process of preparation
US4160861A (en) * 1977-10-03 1979-07-10 Merck & Co., Inc. Method for the separation of antibiotic macrolides
US4894366A (en) 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
JP2639737B2 (ja) 1990-01-23 1997-08-13 寳酒造株式会社 新規ｒ１０６類化合物
US5116756A (en) 1991-01-28 1992-05-26 Merck & Co., Inc. Process for producing FK-506
JPH06501026A (ja) 1991-04-11 1994-01-27 ファイザー・インコーポレーテッド ストレプトミセス・ブレジェンシス由来の新規の免疫抑制剤
US5091389A (en) 1991-04-23 1992-02-25 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant
WO1993018042A1 (en) 1992-03-02 1993-09-16 Pfizer Inc. Desosamino derivatives of macrolides as immunosuppressants and antifungal agents
UA41884C2 (uk) 1993-11-05 2001-10-15 Амерікан Хоум Продактс Корпорейшн Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів
US5622866A (en) 1994-06-23 1997-04-22 Merck & Co., Inc. Expression cassettes useful in construction of integrative and replicative expression vectors for Streptomyces
GB9618952D0 (en) 1996-09-11 1996-10-23 Sandoz Ltd Process
GB9826882D0 (en) 1998-12-07 1999-01-27 Novartis Ag Organic compounds
TW553946B (en) * 1999-09-08 2003-09-21 Fujisawa Pharmaceutical Co Method for separating lactone-containing high-molecular weight compounds
ES2177373B1 (es) 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
FR2803307A1 (fr) * 1999-12-30 2001-07-06 Centre Nat Rech Scient Lignees de lymphocytes t cd4 specifiques de type th1 et procede pour leur induction ex vivo
HRP20020683A2 (en) 2000-02-24 2004-12-31 Biogal Gyogyszergyar Method of purifying a fermentation broth
AUPQ801700A0 (en) * 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
AUPQ923100A0 (en) * 2000-08-07 2000-08-31 Peplin Research Pty Ltd Treatment of prostate cancer
MXPA04007847A (es) 2002-02-13 2005-02-24 Biogal Gyogyszergyar Metodo para extraer un macrolido de biomateria.

Also Published As

Publication number Publication date
PT1558622E (pt) 2007-12-04
WO2005010015B1 (en) 2005-03-17
US7220357B2 (en) 2007-05-22
DE602004010059D1 (de) 2007-12-27
PL1558622T3 (pl) 2008-06-30
DK1558622T3 (da) 2008-02-25
DE602004010059T2 (de) 2008-09-11
KR20060052874A (ko) 2006-05-19
CA2533548C (en) 2010-02-16
ES2297481T3 (es) 2008-05-01
JP2007521013A (ja) 2007-08-02
EP1558622B1 (en) 2007-11-14
US20050027112A1 (en) 2005-02-03
EP1558622A1 (en) 2005-08-03
US20070117976A1 (en) 2007-05-24
CA2533548A1 (en) 2005-02-03
WO2005010015A1 (en) 2005-02-03
ATE378345T1 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
US20070117976A1 (en) Method of purifying macrolides
JP2003508536A (ja) ラクトン含有高分子量化合物の分離方法
CN101084228A (zh) 提纯大环内酯的方法
EP2079748A1 (en) A pure form of rapamycin and a process for recovery and purification thereof
US20060149057A1 (en) Method of purifying macrolides
AU2003286417A1 (en) Process for the purification of macrolides
CN106946907A (zh) 从菌丝体中分离纯化他克莫司的方法及应用
WO2005019226A1 (en) A process for the recovery of substantially pure tricyclic macrolide
CN1856500A (zh) 纯化大环内酯类化合物的方法
KR20070083930A (ko) 타크롤리무스 정제 방법
US8193345B2 (en) Purification method of lactone compounds containing unsaturated alkyl group by extraction with silver ion solution
US7452692B2 (en) Method for extracting a macrolide from biomatter
KR20080039970A (ko) 식물 유래의 지지체 상에서의 타크롤리무스 정제 방법
US20050261493A1 (en) Methods for the isolation and purification of ansamitocins
WO2007013017A1 (en) A process for purification of macrolides
JPH0578538B2 (https=)
JPH0772155B2 (ja) 補酵素ｑの精製法
CN102924413A (zh) 一种霉酚酸莫啡酯纯化脱色方法